RapierMed is a global investment firm established with the early mission of returning compassion to healthcare through strategic investments in life sciences and medical technology. Beyond life sciences, the company participates in an array of opportunities across a broad range of business sectors, applying an investment philosophy based on a disciplined and repeatable process. Our investment approach is dedicated to pursuing strong, consistent risk-adjusted returns across distinct market cycles and macro events. RapierMed manages its own portfolio of companies and provides consulting and management services for clients and affiliates from its office in the United States Virgin Islands. The focused leadership structure allows RapierMed to be quick and decisive in the positions it evaluates, often taking early mover roles in promising companies and projects. RapierMed deploys in-house, proprietary capital, adding greater flexibility and discernment in the projects and opportunities it considers for investment.
The company seeks first to make direct investments on an individual or series basis, but also invests with specialized funds when conditions are compatible to its investment strategy. Potential for success and relative risk tolerance guide the scope and scale of investments, with positions ranging from modest to significant across various sectors.
RapierMed invests both internationally and in the United States.
- Software / Fintech
- Consumer Health Products
- Idea Incubation
- Life Sciences / Rejuvenation Biotech
- Wearable Tech / Digital Therapeutics
- Natural Products
- Hedge & Private Equity Funds
- Cryptocurrencies / Hard Assets
- Direct Investing / Managed Accounts
- Mortgage & Construction Lending
- Mezzanine / Specialty Financing
- Crisis Management
- Buyouts & Business Acquisitions
- Secondaries & Co-investments
- Minority Investments
- Retail / Office / Resort
- Residential Development
- Farmland / Timberland